Wissenschaftliche Arbeiten

Doç. Dr. Fatih Tay

14 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Influence of bone metastases on presentation and management of malignant hypercalcemia: a single-center cohort

    Anatolian Current Medical Journal, 2026

    DOI 10.38053/acmj.1912366 Frei zugänglicher VolltextQuelle: ORCID

  2. Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552261434482 PMID 41885415 Quelle: ORCID

  3. Prognostic value of ALBI score in lung cancer patients with liver metastases and hepatic failure: a single-center experience

    Anatolian Current Medical Journal, 2025

    DOI 10.38053/acmj.1714895 Frei zugänglicher VolltextQuelle: ORCID

  4. A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐ 5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

    Cancer Medicine, 2024

    DOI 10.1002/cam4.70002 PMID 39030808 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  5. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000038828 PMID 39058877 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Gastric cancer patient characteristics in a city in the Central Anatolian Region of Turkey: A single-center descriptive study

    Journal of Current Hematology & Oncology Research, 2023

    DOI 10.51271/jchor-0009 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  7. Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma

    Journal of the College of Physicians and Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.01.32 PMID 36597232 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  8. Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.08.879 PMID 37553926 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.09.1006 PMID 37691362 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Novel inflammatory markers and prognostic importance of platinum-sensitive ovarian carcinoma relapse

    Srpski arhiv za celokupno lekarstvo, 2023

    DOI 10.2298/sarh221122057t 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  11. The Effects of Type 2 Diabetes Mellitus and Hypertension on Survival in Patients with Hepatic Dysfunction and Malignant Solid Tumors

    Eurasian Journal of Medical Investigation, 2023

    DOI 10.14744/ejmi.2023.67812 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Comparison of the Efficiency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.10.1141 PMID 37804020 Frei zugänglicher VolltextQuelle: OpenAlex

  13. Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib

    Journal of Oncology Pharmacy Practice, 2022

    DOI 10.1177/10781552221083321 PMID 35225067 Frei zugänglicher VolltextQuelle: ORCID

  14. Factors contributing to survival in hepatic dysfunction due to colorectal cancer

    Srpski arhiv za celokupno lekarstvo, 2022

    DOI 10.2298/sarh220725097t 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID